CD115, encoded by the Csf1r gene, is a receptor tyrosine kinase critical for monocyte/macrophage differentiation, osteoclastogenesis, and tumor-associated macrophage (TAM) regulation. It binds CSF-1 and IL-34, activating pathways for cell survival, proliferation, and immune modulation.
Key Anti-CD115 Antibodies
Antibody Name
Target Species
Applications
Key Findings
Source
AFS98
Mouse
Flow cytometry, Western blot, immunotherapy
Blocks CSF-1 binding, inhibits tumor growth in EL4 and PyMT models, depletes M2-polarized TAMs, synergizes with chemotherapy.
MAB3291
Human
Western blot, M-CSF-dependent cell proliferation assays
Neutralizes M-CSF activity, detects ~130 kDa band in THP-1 lysates.
Mechanisms and Therapeutic Applications
Cancer Immunotherapy:
AFS98 delays tumor growth in murine models (e.g., EL4 lymphoma, PyMT mammary tumors) by depleting pro-tumorigenic M2 macrophages.
Reduces osteoclast differentiation and bone metastasis in breast cancer models.
Autoimmune/Inflammatory Disorders:
CD115 inhibition modulates macrophage-driven inflammation, though clinical data in humans remain limited.
Research Gaps and Limitations
No studies explicitly address an antibody named "mug115."
Most data derive from preclinical mouse models; human clinical trials for anti-CD115 antibodies are sparse.